Jordan D. Campbell

Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer

Aranzazu Fernández-Martínez, Tomás Pascual, Baljit Singh et al. · JAMA Oncology · 2023 · 75 citations · Full text

Medicine, Cancer Biology, Oncology +17

Phase II Study of Enzalutamide for Patients With Androgen Receptor–Positive Salivary Gland Cancers (Alliance A091404)

Alan L. Ho, Nathan R. Foster, Alexander Zoroufy et al. · Journal of Clinical Oncology · 2022 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16

Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance)

Anna Weiss, Jordan D. Campbell, Karla V. Ballman et al. · Annals of Surgical Oncology · 2021 · 40 citations · Full text

Medicine, Oncology, Breast Oncology +14

Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival

Marla Lipsyc-Sharf, Karla V. Ballman, Jordan D. Campbell et al. · JAMA Network Open · 2023 · 17 citations · Full text

Medicine, Oncology, Breast Oncology +16

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials

Mattia Rediti, Aranzazu Fernández-Martínez, David Venet et al. · Nature Communications · 2023 · 16 citations · Full text

Medicine, Immunology, Oncology +17